Matrix metalloproteinase inhibitors of tgf .beta.-induced...

Details Matrix metalloproteinase inhibitors of tgf .beta.-induced... Matrix metalloproteinase inhibitors of tgf .beta.-induced...

A - Human Necessities

61

K

A61K 31/4045 (2006.01) A61F 2/16 (2006.01) A61K 31/16 (2006.01) A61K 38/55 (2006.01) A61K 45/06 (2006.01) A61P 27/12 (2006.01)

Patent

CA 2605783

The present invention provides novel methods and compositions for the treatment and/or prevention of cataracts. A composition that inhibits destabilization of E-cadherin is administered. Preferably the composition comprises a matrix metalloproteinase inhibitor.

Procédés et compositions pour le traitement et/ou la prévention de la cataracte. On administre une composition inhibant la déstabilisation de l'E-cadhérine, et de préférence ladite composition renferme un inhibiteur de métalloprotéinase matricielle.

Affiliated with

Also associated with

Rating

Matrix metalloproteinase inhibitors of tgf .beta.-induced... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Matrix metalloproteinase inhibitors of tgf .beta.-induced..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Matrix metalloproteinase inhibitors of tgf .beta.-induced... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1394592